Exploring New Ways to Understand and Prevent Cancer
NCT02012699 · RecruitingThis trial creates a resource called iCaRe2 to gather and manage data about cancer. It focuses on adult cancer patients and healthy individuals. The goal is to study risk factors for cancer and develop new ways to prevent and treat it. By including many hospitals, especially in small or rural areas, this project aims to improve cancer research across diverse populations.
Locations and contact
This trial is running at 42 locations in the United States. All of them are currently recruiting.
United States42 locations · 42 recruiting
- Advent HealthGreenwood Village, ColoradoRecruiting
- Aultman Alliance Community HospitalAlliance, OhioRecruiting
- Aultman HospitalCanton, OhioRecruiting
- Bellin Memorial HospitalGreen Bay, WisconsinRecruiting
- Bozeman Health Deaconess HospitalBozeman, MontanaRecruiting
- C.R. Wood Cancer Center, Glens Falls HospitalGlens Falls, New YorkRecruiting
- Cape Fear Valley Health SystemFayetteville, North CarolinaRecruiting
- Covenant Medical Center, IncWaterloo, IowaRecruiting
- Essentia HealthFargo, North DakotaRecruiting
- Essentia Health - Duluth ClinicDuluth, MinnesotaRecruiting
- Essentia Health-St. Joseph's Medical CenterBrainerd, MinnesotaRecruiting
- Faith Regional Health Services, Carson Cancer CenterNorfolk, NebraskaRecruiting
- Faxton St. Luke's Healthcare, Mohawk ValleyUtica, New YorkRecruiting
- Florida Hospital DeLandDeLand, FloridaRecruiting
- Florida Hospital FISHOrange City, FloridaRecruiting
- Florida Hospital FlaglerPalm Coast, FloridaRecruiting
- Florida Hospital Memorial Medical CenterDaytona Beach, FloridaRecruiting
- Great Plains Regional Medical CenterNorth Platte, NebraskaRecruiting
- Hartford HealthCare Cancer Institute at Manchester Medical HospitalManchester, ConnecticutRecruiting
- Heartland Regional Medical Center dba Mosaic Life CareSaint Joseph, MissouriRecruiting
- Holyoke Medical CenterHolyoke, MassachusettsRecruiting
- Lake Region HealthcareFergus Falls, MinnesotaRecruiting
- Mary Lanning Healthcare, Morrison Cancer CenterHastings, NebraskaRecruiting
- Methodist Estabrook Cancer CenterOmaha, NebraskaRecruiting
- Methodist Jennie Edmundson HospitalCouncil Bluffs, IowaRecruiting
- Nebraska Methodist Health SystemOmaha, NebraskaRecruiting
- North Kansas City HospitalNorth Kansas City, MissouriRecruiting
- Northwest HospitalRandallstown, MarylandRecruiting
- Parkview Research CenterFort Wayne, IndianaRecruiting
- Riverwood Healthcare CenterAitkin, MinnesotaRecruiting
- Rush-Copley Cancer Care CenterAurora, IllinoisRecruiting
- Rush-Copley Healthcare CenterYorkville, IllinoisRecruiting
- Saint Luke's Cancer Instititute - SouthOverland Park, KansasRecruiting
- Saint Luke's Cancer InstituteKansas City, MissouriRecruiting
- Saint Luke's Cancer Institute, EastKansas City, MissouriRecruiting
- Saint Luke's Cancer Institute, Kansas City NorthKansas City, MissouriRecruiting
- Saint Luke's Cancer Institute, LibertyLiberty, MissouriRecruiting
- St. Luke's Hospital of DuluthDuluth, MinnesotaRecruiting
- Tallahassee Memorial HospitalTallahassee, FloridaRecruiting
- Trinity Hospital Cancer Care CenterMinot, North DakotaRecruiting
- University of Nebraska Medical CenterOmaha, NebraskaRecruiting
- William E. Kahlert Regional Cancer CenterWestminster, MarylandRecruiting
Who can join
Anyone aged 19 or older can join if they have a history of cancer, are at risk for cancer, or are healthy. Both men and women are welcome. Individuals must be able to give informed consent and speak English or Spanish. Those unable to provide consent due to cognitive issues cannot participate.
What happens during the trial
Participants will provide data and possibly biospecimens, like blood or tissue samples. This information will help create a web-based registry for cancer research. The registry will be available for various centers to use for research projects.
The trial team
The trial is sponsored by the University of Nebraska. Dr. Kurt Fisher is the principal investigator leading the study.
Important dates
The trial started on November 1, 2013, and is currently recruiting participants. It is expected to finish around December 2099.
Additional information
The trial's ID number is NCT02012699. This is an observational study, meaning it will observe and collect data without giving any treatment. The trial is not regulated by the FDA as a drug or device, and it hopes to include a large number of participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →